Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    Open Studies | "Coronavirus Infections"
Show Display Options
Rank Status Study
1 Not yet recruiting A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
Condition: Severe Acute Respiratory Syndrome
Intervention: Drug: Lopinavir / Ritonavir plus Ribavirin
2 Recruiting The Respiratory Protection Effectiveness Clinical Trial
Conditions: Influenza;   Respiratory Syncytial Viruses;   Paramyxoviridae Infections;   Coronavirus;   Rhinovirus
Interventions: Device: N95 Respirator;   Device: Medical/surgical mask
3 Not yet recruiting Anti-MERS-COV Convalescent Plasma Therapy
Condition: Respiratory Distress Syndrome (& [Hyaline Membrane Disease])
Intervention: Biological: Convalescent plasma

Indicates status has not been verified in more than two years